Influence of the Pre-Analytical Specimen Storage Conditions on the Fecal Occult Blood Test Results

被引:3
作者
Yoo, Soo Jin [1 ]
Moon, Se Jin [1 ]
Gwack, Eun-Hye [1 ]
Shin, Bo-Moon [1 ]
机构
[1] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Lab Med, Seoul 139707, South Korea
来源
KOREAN JOURNAL OF LABORATORY MEDICINE | 2009年 / 29卷 / 03期
关键词
Fecal occult blood; Pre-analytical error; Colorectal carcinoma; Screen; COLORECTAL-CANCER; IMMUNOCHEMICAL TEST; PERFORMANCE-CHARACTERISTICS; POPULATION; HEMOGLOBIN; PARTICIPATION;
D O I
10.3343/kjlm.2009.29.3.262
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background : Korean national cancer screening program selected fecal occult blood test (FOBT) as a primary screening method of colorectal carcinoma in adult >= 50 yr old irrespective of symptom. Notice to pre-analytical errors is especially important for the FOBT because examinees collect and submit their specimens to laboratories by themselves. We examined the influences of the fecal storage temperatures, durations and with or without buffer on the FOBT results. Methods : Thirty FOBT-positive specimens above 100 ng/mL were used for the study from July to August 2008. Quantitative FOBT was performed with OC-sensors II (Eiken Chemical Co., Japan). Each specimen was divided into 4 groups. Two groups in plastic buffer-free containers were kept either at 4 degrees C or room temperature (25-28 degrees C), respectively. Another two groups in buffer-tubes were also kept either at 4 degrees C or room temperature. Each group was repeatedly examined with same method every 24 hr up to 120 hr. Results : Eleven specimens (36.7%) in buffer-free containers converted to negative results (below the 100 ng/mL) after 24 hr and 17 specimens (56.7%) did after 48 hr at room temperature. Ten specimens (33.3%) in buffer-free containers converted to negative after 48 hr at 4 degrees C. Specimens contained in buffer-tubes showed little change; 3 specimens (10.0%) at room temperature and no specimen at 4 degrees C showed negative conversions after 48 hr. Conclusions : Buffer-tube minimizes false negative FOBT results during pre-analytical delay of specimen. The examinees using buffer-free containers need to be educated to hand in their specimens to laboratories as soon as possible. (Korean J Lab Med 2009;29:262-7)
引用
收藏
页码:262 / 267
页数:6
相关论文
共 18 条
  • [1] Stool screening for colorectal cancer: evolution from occult blood to molecular markers
    Ahlquist, DA
    Shuber, AP
    [J]. CLINICA CHIMICA ACTA, 2002, 315 (1-2) : 157 - 168
  • [2] A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer
    Cole, SR
    Young, GP
    Esterman, A
    Cadd, B
    Morcom, J
    [J]. JOURNAL OF MEDICAL SCREENING, 2003, 10 (03) : 117 - 122
  • [3] Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer
    Cole, SR
    Young, GP
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2001, 175 (04) : 195 - 198
  • [4] HAN WS, 1996, KOREAN J CLIN PATHOL, V16, P318
  • [5] *KOR NAT STAT OFF, 2007 DEATH DEATH CAU
  • [6] Randomised study of screening for colorectal cancer with faecal-occult-blood test
    Kronborg, O
    Fenger, C
    Olsen, J
    Jorgensen, OD
    Sondergaard, O
    [J]. LANCET, 1996, 348 (9040) : 1467 - 1471
  • [7] Colorectal cancer screening in Finland: details of the national screening programme implemented in Autumn 2004
    Malila, N
    Anttila, A
    Hakama, M
    [J]. JOURNAL OF MEDICAL SCREENING, 2005, 12 (01) : 28 - 32
  • [8] The effect of fecal occult-blood screening on the incidence of colorectal cancer
    Mandel, JS
    Church, TR
    Bond, JH
    Ederer, F
    Geisser, MS
    Mongin, SJ
    Snover, DC
    Schuman, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) : 1603 - 1607
  • [9] REDUCING MORTALITY FROM COLORECTAL-CANCER BY SCREENING FOR FECAL OCCULT BLOOD
    MANDEL, JS
    BOND, JH
    CHURCH, TR
    SNOVER, DC
    BRADLEY, GM
    SCHUMAN, LM
    EDERER, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (19) : 1365 - 1371
  • [10] Ministry of Health & Welfare and National Cancer Center, 2008, QUAL GUID COL CANC S, P14